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Abstract 
 
 
Topic 
Technological change represents a huge opportunity for those organisations that are able to 
identify new technologies early and anticipate their future evolution and impact. On the other 
hand, technological change is a key challenge for organisations, particularly for those that have 
limited resources for monitoring and developing emerging technologies or for adopting 
technologies that already exist in other industries/sectors. Specifically, new technology 
adoption by SMEs faces barriers because new technologies create different layers of 
uncertainty which hampers investments and the commitment of resources.  
 
Applicability to the conference theme –exploring new frontiers and entrepreneurial 
places 
The main objective of this research work is to boost the productivity and long-term 
competitiveness of UK SMEs by helping them to cope with the uncertainty of technological 
change and benefit, at the same time, from first mover advantages. Precisely, our paper seeks 
to provide SME managers with an innovative methodological approach to technology 
foresight, tailored to the specific needs (and constraints) of SMEs. Our target audience of SMEs 
for technology foresight are SMEs that operate in clusters. 
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Aims 
Since the early 2000s, a significant number of corporate organisations successfully applied an 
innovative management approach to the monitoring of new technologies and the systematic 
analysis of their future evolution and impact. Despite the growing popularity of technology 
foresight amongst large corporations, there is little evidence on its use in SMEs. However, 
foresight might be very beneficial to SMEs that are facing technological changes, by enabling 
them to pool their knowledge about new technologies and thus to set priorities and joint efforts, 
in a systematic way, for the optimal allocation of their resources.  
 
This paper aims to develop and test a simple, effective and scalable foresight method 
specifically responding to the needs (and challenges) of SMEs in UK clusters. We illustrate the 
results of a foresight exercise that involved 16 SMEs in the London Digital Health cluster. The 
main novelty of this foresight exercise is related to the involvement of different entrepreneurs 
of different SMEs (rather than a team of managers from the same organisation, as it is usually 
the case of technology foresight in large corporations) and the adoption of a bespoke set of 
different techniques, tailored to the specific needs of SMEs.   
 
Methodology 
The results of this paper are based on an action research project. Precisely, we illustrate the 
results of the project “Technology foresight for growth and productivity: the design and 
implementation of a new foresight approach for UK SMEs” we implemented after we 
attained a research grant from Innovate UK, within the “Business Basics” programme that 
was launched in July 2018. 
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Results 
The foresight project consisted of three different main phases. The first phase focused on the 
identification of the SMEs to involve in the project (overall, 16 companies), the identification 
of the technology experts to involve in the project (overall, 6 experts), the raising of awareness 
among the entrepreneurs and experts, the gathering of background information, the 
identification of a preliminary list of technologies that are potentially relevant for future SMEs’ 
productivity.  
 
The second phase of the project consisted of a 3-round Delphi process enabling the evaluation 
of the preliminary list of technologies selected in the previous phase and the identification of 
the most relevant technologies for the target cluster of SMEs. The Delphi involved all the 
technology experts and SMEs entrepreneurs. The third phase consisted of two of workshops 
through which all the entrepreneurs and technology experts will meet and use the foresight 
technique of technology road-mapping to assess the evolution, impact (e.g. new products and 
process), and response options available for adopting/developing the critical technologies 
identified in the previous phase.  
 
Contribution and Implications 
This research project produced three main outputs leading to improvement in the productivity 
of SMEs. The first, is a foresight methodology that proved to be effective, scalable, and easy 
to use by UK SMEs, especially those operating in clusters, for identifying and developing 
emerging technologies. The second is a list of critical technologies (e.g., artificial intelligence) 
specifically aimed at improving the productivity of the SMEs of the Digital Health cluster. The 
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third output is a list of key actions enabling these same firms to concretely adopt these 
technologies and ultimately to enhance their productivity and growth.  
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1. Introduction 
 
 
Technological change is a key challenge for any organization, especially for SMEs that have 
limited resources for monitoring and developing new technologies or transferring existing 
technologies from other business sectors (Nguyen et al., 2015). Yet, technological change 
represents a huge opportunity for boosting the productivity of SMEs (BEIS, 2018). 
Organisations that are able to identify early new technologies and anticipate their future 
evolution can achieve significant “first mover advantages” and thereby higher profits and 
market shares. Technology ‘foresight’ is a modern management practice that can be very 
effective at fostering the adoption and diffusion of new technologies among SMEs and thus 
contribute to  boosting their productivity (Roveda and Vecchiato, 2008). This research aims to 
develop a simple, effective, and scalable ‘foresight’ method that enables SMEs to (i) identify 
promptly relevant technologies, (ii) assess their potential risks and opportunities and (iii) set 
out priorities for their adoption in a rational way.  
 
The main novelty of this research is to design and implement a bespoke set of foresight 
techniques, tailored to the specific needs of SMEs. This approach differs from usual foresight 
activities in large corporations that involve a team of managers belonging to the same 
organisation. On the one hand, this foresight project has predicted a list of critical technologies 
and actions that SMEs can implement in order to ultimately improve their productivity. On the 
other hand, outcomes of the project has generated the development of networks that foster the 
cooperation and integration of SMEs, by developing links with external partners including 
universities, technology providers, and funding institutions.   
 
This paper is structured as follows. First, we illustrate recent findings in literature on foresight, 
technological change, and SME management. Then we describe our methodology and our 
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foresight project and in section 4 we illustrate the main outputs of the project, i.e., the foresight 
methodology, the list of critical technologies, and the list of key actions for their transfer to 
SMEs. Finally, we discuss the lessons learnt and propose avenues for future research.  
 
 
2. Technological change, foresight, and SME management  
2.1 Technological change and uncertainty 
Technological change is a key challenge for organisations, particularly for SMEs that have 
limited resources for monitoring and developing emerging technologies or for adopting 
technologies that already exist in other industries/sectors (BEIS, 2018; Vecchiato and Roveda, 
2014).  In the remainder of this paper, we use the term “new technologies” to refer to both 
emerging technologies and existing technologies that might be transferred from other 
industries/sectors. Specifically, new technology adoption by SMEs may face barriers because 
they create different layers of uncertainty which hampers investments and the commitment of 
resources (Milliken, 1987).  
 
The first kind of uncertainty regards the evolution of a new technology (i.e., ‘state’ 
uncertainty): managers experience such kind of uncertainty when they do not feel able to 
understand the future pattern of evolution of this technology. A second kind relates to 
managers’ inability to predict the impact of a new technology on the organization (i.e., ‘effect’ 
uncertainty), with regard for instance to the development of new product or service features (or 
radically new product or services) or to the improvement of current features. Finally, a third 
kind of uncertainty relates to the difficulty of understanding what response options are available 
to the organisation and what is the value or utility of each option is (i.e., ‘response’ uncertainty). 
Coping with the uncertainty surrounding new technologies is generally difficult for large 
corporations but it is definitely more challenging in the case of SMEs because of their limited 
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access to data and knowledge (both tacit and explicit) about the state, effect and response to 
new technologies (Roveda and Vecchiato, 2008).  
 
Technological change, however, presents a huge opportunity for those organisations that are 
able to identify new technologies early and anticipate their future evolution, impact and 
response options (Peltier and Zhao, 2012; Nguyen, 2015; Solomon and Linton, 2016). In this 
regard, mainstream scholars define as “first mover advantages” the main benefits that a firm 
might gain by anticipating – and thus by pioneering – technological changes and, conversely, 
the disadvantages encountered by late mover firms that fail to anticipate such changes (Suarez 
and Lanzolla, 2007; Vecchiato, 2015). The main sources of first mover advantages lie in three 
basic categories: superior technological capabilities, customers’ switching costs, and pre-
emption of scarce inputs or assets.  
 
Technological capabilities result from the ‘learning’ curve, where costs fall with cumulative 
output, or more simply from superior knowledge, where competitive edges in product or 
process features are a function of innovation expenditures. Customers’ switching costs relate 
to the extra resources which late movers must invest in order to attract customers away from 
the first mover firms; switching costs can stem from initial transaction costs or investments that 
customers make in adapting to the first movers’ products. Finally, the pre-emption of scarce 
assets might regard physical resources, process inputs or geographic space or customers’ 
perceptual space. First mover advantages tend to be observed mainly in the form of higher 
profits and market share: the longer the time a firm anticipate new technologies before its rivals, 
the higher the likelihood of achieving such benefits.  
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2.2 Foresight and uncertainty management 
Since the early 2000s, a significant number of corporate organisations successfully applied an 
innovative management approach to the monitoring of new technologies and the systematic 
analysis of their future evolution and impact (Vecchiato, 2012; Georghiou et al., 2008). Such 
approach is commonly named under the umbrella of “technology (or strategic) foresight” and 
includes techniques like technology roadmapping and Delphi. Roadmapping consists of 
representations as interconnected nodes of major changes and events in the external 
environment, such as new technologies, products, and markets. Delphi involves a number of 
experts answering a questionnaire in two or more rounds. After each round, the experts are 
given a summary of average forecasts and the reasons for such forecasts, and are encouraged 
to revise their early answers in the light of this feedback.  
 
Despite the growing popularity of technology foresight amongst large corporations, there is 
little evidence on its use in SMEs. However, foresight might be very beneficial to SMEs that 
are facing technological changes, by enabling them to pool their knowledge about new 
technologies and thus to set priorities and joint efforts, in a systematic way, for the optimal 
allocation of their resources (Roveda and Vecchiato, 2008). This is particularly true for SMEs 
that operate in clusters.  
 
A cluster is a geographically proximate group of interconnected companies and interrelated 
institutions in a particular industry or business area. On the one hand, clusters are a relevant 
driver of the competitiveness and innovation capability of a region or country (Porter, 1990). 
On the other hand, technology innovation in industrial clusters is extremely complex as it 
involves a wide set of autonomous players, on both a vertical dimension (providers of 
complementary products, services, components and machines) and a horizontal dimension 
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(small and medium firms providing the same kind of products and/or services). In order to be 
successfully adopted, a new technology requires that all these different and autonomous players 
coordinate their efforts into the implementation of the new technology (Roveda and Vecchiato, 
2008).  
 
The micro-economic fabric of a cluster of SMEs, namely its fragmentation across a mass of 
firms, is thus an essential condition for the continuous enrichment and evolution of the 
knowledge underlying the technologies that are currently applied within the cluster. At the 
same time, this fabric turns out to be the hardest obstacle to the adoption of new technologies. 
The shared culture and behavioural patterns which work so well in relation to the incremental 
evolution of current technologies, hardly allow a cluster of SMEs to embrace the paradigmatic 
shifts associated with new technologies – unless a critical mass of SMEs becomes aware of the 
benefits that these technologies may bring in terms of cost savings, increased productivity, or 
product differentiation and this critical mass leads the transition of other SMEs within the 
cluster. 
 
Technology foresight has already been proved to be a modern, effective management approach 
which brings concrete benefits to the participants, especially: communication; consensus; co-
ordination; concentration on the longer term; and commitment (Martin, 1995). These outcomes 
are commonly labelled as the “5Cs” of foresight and might have a key role in fostering 
technological change in SME clusters, by fostering the creation of networks among the SMEs 
participating in our foresight project and ultimately by enhancing their cooperation and 
integration for the development/adoption of new technologies. However, scarce research 
investigates the use of technology foresight in SMEs. This research project, hence, fills a gap 
in extant literature on SME and innovation, by developing and testing a new foresight method 
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aimed exactly at coping with the challenges inherent in the micro-economic fabric of a cluster 
of SMEs.  
 
 
3. Methodology 
 
3.1. Sampling 
The research was conducted with a group of 16 Digital Health SMEs based in London. The 
sector and cluster of SMEs was selected according to such criteria as its impact on the UK 
economy, its impact on NHS services, and the potential/need for enhancing its current level of 
productivity (NESTA, 2017; ONS, 2017). The novelty of this foresight exercise is related to 
the involvement of different entrepreneurs of different SMEs (rather than a team of managers 
from the same organisation, as it is usually the case of technology foresight in large 
corporations) and the adoption of a  bespoke set of different techniques, tailored to the specific 
needs of SMEs.   
 
The added value of this research derives from the fact that the SMEs of the selected Digital 
Health cluster can process a wider range of information about new technologies than if they 
would have to work separately. By allowing these SMEs to have an active role in the 
identification of the new technologies that are critical to them, we increased the likelihood that 
these firms adopt these new technologies – and conversely reduce the risks that new 
technologies are rejected or that public money is not effectively used. Ultimately, in this project 
we gave SMEs the concrete chance of working together and coordinating their efforts not only 
amongst themselves but also with UK policy makers and other funding institutions. 
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3.2. Foresight method 
This foresight method consisted of three different main phases. The first phase focused on the 
identification of the SMEs to involve in the project (target number: 15), the identification of 
the technology experts to involve in the project (target number: 5), the raising of awareness 
among the entrepreneurs and experts, the gathering of background information, and the 
identification of a preliminary list of technologies that are potentially relevant for future SMEs’ 
productivity. The identification of the relevant technologies was based on techniques such as: 
a) an analysis of patenting activity by leading organisations (e.g., corporate firms and research 
centres) operating in the Digital Health sector, at an international level; b) a bibliometric 
analysis of publications; c) an analysis of project proposals funded by public bodies (e.g. the 
Horizon 2020 of the EU); d) a survey (involving all the SMEs entrepreneurs and technology 
experts). 
 
The second phase of the project consisted of a 3-round Delphi process enabling the evaluation 
of the preliminary list of technologies selected in the previous phase and the identification of 
the most relevant technologies for the target cluster of SMEs. The evaluation is based on two 
dimensión: the attractiveness and the feasibility of 16 listed relevant technologies in the digital 
health sector. The Delphi process involved all the technology experts and SMEs entrepreneurs.  
This enabled the participants to compare their previous scores with the average score and 
comment on different types of technology, and to determine either to keep or change their 
scores in the second and third round of the Delphi process.  
 
The third phase consisted of two of workshops through which all the entrepreneurs and 
technology experts met and assessed the evolution, impact (e.g. new products and process), 
and response options available for adopting/developing the critical technologies identified in 
12 
 
the previous phase. In particular, the two workshops explored the joint actions enabling the 
SMEs to overcome the limitations - e.g., expertise, financial – of each individual firm.  
 
 
3.3. Key activities 
Phase 1 
The first phase of the project was conducted between November 2018 and January 2019.  
A preliminary search of innovative digital health SMEs based in the London area pointed out 
that many of these companies were linked to the Digital Health London Accelerator (DHLA). 
We approached the managers of the DHLA and subsequently established a strong and effective 
collaboration. Together, we identified 15 companies that volunteered to take part in the project. 
One further company was enrolled after the suggestion of a technology expert. The manager 
of each company was interviewed by a member of our project team. During the interview 
meetings, we explained the methodology we were going to apply in the next Delphi process. 
After the interviews, two managers withdrew, due to other commitments or because they didn’t 
feel comfortable with the technology evaluation process. Altogether, 14 companies took part 
in the Delphi. 
 
Contextually, we identified six technology experts: three belonged to DHLA and three from 
the Computer Science Department, Kingston University. The experts were identified on the 
basis of their skills and current activities in the digital health sector. 
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Contextually, based on both Google Scholar and IEEE Explore search engines, we selected 
almost 600 scientific publications covering the adoption of ICTs in the healthcare domain. 
Analysing these papers (mainly published between 2013 and 2018) we are able to undertake 
an up-to-date review of the scientific literature. This helped the identification of the main ICTs-
based healthcare paradigms developed in the last few years, as well as the ICTs paradigms and 
the ICTs technology pillars that underpin them. At the same time, we carried out desk research 
(internet sources, business and media press) covering recent foresight exercises in the 
healthcare sector, at an international level, and future oriented publications depicting futures 
scenarios for digital health applications and technologies. Our desk research also covered the 
white papers of national governments in the EU, USA and Asia regarding the evolution of 
healthcare. This also included the UK Government’s White Paper on “The future of healthcare: 
our vision for digital, data and technology in health and care (published on October 17th 2018). 
Finally, we monitored recent trends in related sectors including Home Automation, Digital 
Media, Digital Game and Self-Driving Cars, searching for new technologies that might be 
transferred to the Digital Health sector.  
 
The results of this research was a preliminary list of 26 technologies that might affect the future 
evolution of the digital health sector and have an impact upon the future growth (or even the 
survival) of digital health companies, especially UK SMEs. We classified these 26 technologies 
in 4 main categories: communication; hardware; software; transversal technologies 
(technologies that involve 2 or more of the above domains or might be transferred from other 
industries).  These 26 technologies are: 
1. Machine to machine communication 
2. Internet of things 
3. Cloud computing 
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4. Fog computing and Mobile Edge computing 
5. Wireless body area networks communication protocols 
6. Wireless body area networks  
7. Wireless sensors (wearables) 
8. Smart devices  
9. Robotics 
10. Smart e-health systems  
11. 3D printing 
12. Health Data Formats 
13. Big data analytics 
14. Artificial Intelligence 
15. Image analysis and facial recognition 
16. Speech recognition and chatbots 
17. Social media 
18. Security and privacy (cryptography) 
19. Augmented reality and virtual reality 
20. Biometrics 
21. Blockchain 
22. Micropayments 
23. Technologies from self-driving cars  
24. Automated Transport Systems (drones, autonomous ambulance)  
25. New touch interfaces and displays  
26. Human augmentation  
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Phase 2 
The second phase of the project included a 3-round Delphi process for the evaluation of the list 
of digital health technologies identified in the previous phase. This took place between mid-
January 2019 and mid-April 2019. The third phase involved organising a workshop to deliver 
the findings of the projects; hold interactive discussions between SME owner-managers, 
experts and researchers to analyse the impact and evolution trends of the key technologies; and 
generate the list of actions to enable SMEs to adopt new technologies. The workshop was held 
on April 29th 2019. 
Hereafter in this section we describe the methodology developed and applied in the 
evaluation process. The evaluation specifically focused on the digital health SMEs based in the 
London area, especially the SMEs of the Digital Health London Accelerator. The following 
subsection presents the instructions that were shared with the SMEs owner-managers. 
 
Attractiveness evaluation. The attractiveness of a given technology refers to its capability to 
improve products (or services) and product features and thereby foster the competitiveness (and 
ultimately the sales and profits) of digital health companies. You are given 8 points: please 
distribute these 8 points among the 26 technologies (e.g., 1 point each allocated to 8 
technologies, or 2 points each allocated to 4 technologies, or 3 points each to 2 technologies 
and 1 point each to two other technologies, etc. You might even give all the 8 points to just one 
technology). Please repeat this process for each one of the following four criteria and, after 
that, provide an overall evaluation for the attractiveness of the technologies. 
 
Attractiveness criteria  1a) Economic impacts: these regard the size (number of 
customers, potential sales) and dynamics (rate of growth) of the 
markets for the technology in the UK. The economic impacts 
regard as well the opportunity for exporting new 
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services/products based on the technology into foreign markets, 
e.g., EU or the Commonwealth. The attractiveness of a 
technology increases when the economic impacts are high - so the 
higher you think the economic impacts of a given technology are, 
the more points you might allocate to this technology.  
1b) Competition: Intensity of competition from foreign 
companies (other EU countries, US, Asia) that are developing as 
well the technology and new products/services that are based on 
the technology. The attractiveness of a technology decreases 
when the intensity of competition is high.- so the lower you think 
the competition for a given technology is, the more points you 
might allocate to this technology.  
1c) Uncertainty: Uncertainty regarding the future development of 
the technology (i.e., capability of the technology to eventually 
provide the expected benefits). The attractiveness of a technology 
decreases when the uncertainty is high, so the lower you think the 
uncertainty about a given technology is, the more points you 
might allocate to this technology.  
1d) Please evaluate the OVERALL attractiveness of the 
technologies – the more attractive you think a technology is, the 
more points you might allocate to this technology.  
 
 
Feasibility evaluation. Feasibility links a given technology with the concrete capability of 
digital Health SMEs to develop or adopt this technology. 
 
Please select the four technologies that you consider to be the most feasible. These four 
technologies might NOT be those that you have considered to be the most attractive. Please 
repeat this process for each one of the following three criteria and, after that, provide an overall 
evaluation for the feasibility of the technologies. 
 
Feasibility criteria  2a) Capabilities: Technology capabilities (assets and knowledge 
available in the UK industrial and scientific system, companies – 
17 
 
both large and SMEs – representing potential partners, suppliers, 
universities, public research centres), especially in the London 
area, for developing the technology. The feasibility of a 
technology increases when technology capabilities are high - so 
the higher you think the capabilities available for a given 
technology are, the more points you might allocate to this 
technology. 
2b) Congruence: Congruence of the technology to the UK socio-
economic system, in relation to the local demand (e.g., NHS, 
demographics of population), complementary technologies in 
related sector (e.g., game industry or automotive industry, local 
(regional and national) regulation. The feasibility of a technology 
increases when the congruence is high - so the higher you think 
the congruence of given technology is, the more points you might 
allocate to this technology. 
2c) Technological investments, i.e., the average amount of 
financial resources necessary for a company to gain the 
competences and assets needed to adopt the technology and 
provide competitive products/services based on the technology 
itself. The feasibility of a technology decreases when the 
technology investments are high - so the lower you think the 
investments necessary for a given technology are, the more points 
you might allocate to this technology. 
2d) Please evaluate the OVERALL feasibility of the technologies 
- the more feasible you think a technology is, the more points you 
might allocate to this technology.  
 
 
At the end of the first Delphi round, the points allocated by all the participants for each 
technology were added up, in relation to each criterion and to the overall attractiveness and 
feasibility. We asked participants to comment on the overall scores received by each 
technology regarding the overall attractiveness and feasibility evaluation. The participants 
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were given a table to provide their opinions for any technology they wish to comment on. (The 
participants did not need to consider all the technologies in the table: they could just focus on 
a few technologies, i.e., those 3-4 technologies for which they particularly agreed or disagreed 
with the scores received in the previous Delphi round).  
Finally, a third round took place when participants were asked to repeat the attractiveness 
and feasibility evaluation of each technology (as in Round 1 of the Delphi) in the light of the 
feedback received from the previous (second) round of the Delphi exercise. The criteria and 
procedure were exactly the same applied in the first round of the Delphi. They has the option 
to either change or confirm their evaluations in the first round. In addition, they were asked to 
repeat the process only in relation to the criteria of Overall Attractiveness and Overall 
Feasibility. 
At the end of the third round of the Delphi exercise, the participants highlighted the 
technologies that result to be the most critical for UK SMEs operating in the digital health 
sector, i.e., the technologies that result to be, at the same time, the most attractive and feasible. 
These technologies, therefore, represent the main priorities for future investments.  
In the next section of the report, we discuss the findings of the technology evaluation process.  
 
After the third Delphi round concluded, in late April two workshops were held with the 
partucpation of both the SME managers and the technology experts. The objective of the first 
workshop was to explore further the evolution of the critical technologies for Digital Health 
SMEs identified in the Delphi and their impact on future products and services and, more 
generally, the future growth of Digital Health SMEs. We also presented the aggregated results 
of the preliminary interviews we conducted with all the company managers, in relation to the 
main barriers and enablers of technology innovation in Digital Health SMEs. The objective of 
the second workshop was to explore the options available to SMEs for adopting/developing 
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the new technologies (especially joint actions enabling SMEs to overcome the limitations - 
e.g., expertise, financial – of each individual firm). 
 
4. Results 
Critical technologies. The key output of the Delphi process was a set of critical technologies 
that were both attractive and feasible based on the original 26 identified from the literature. 
These represent the priorities for the future investments of the London based SMEs, especially 
those of the Digital Health London Accelerator. Precisely, four key technologies (i.e. the most 
attractive and feasible technologies for London–based digital health SMEs) from the first 
Delphi Round 
1. Artificial intelligence 
2. Big data Analytics 
3. Internet of things 
4. Smart devices 
 
The results of the third round of the Delphi process confirmed the results of the first round, by 
actually increasing the overall scores and relative prominence of the four key technologies 
identified in the first phase. Four technologies clearly stood out in terms of both Attractiveness 
and Feasibility according to the experts and SME managers. This is quite unusual (generally 
the technologies that are the most attractive are not the most feasible) but very encouraging.  
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Figure 2. Result of the third Delphi round  
 
 
 
At the end of the Delphi, the results were compared with the analysis of the citations of 
the 26 technologies of the Web of Science database. (i.e. the number of scientific articles 
mentioning the technologies in the title, abstract, or keywords). The Web of Science is an online 
subscription-based scientific citation indexing service providing a comprehensive citation 
search. It gives access to multiple databases that reference cross-disciplinary research, which 
allows for in-depth exploration of specialized sub-fields within an academic or scientific 
discipline. 
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This comparison revealed that the four key technologies stemming from the Delphi 
exercise are not those receiving the highest levels of the attention in the scientific literature.  
This is a result of the different focus of the Delphi and Web of Science citation analysis: while 
the Delphi focused on UK digital health SMEs based in the London area, the Web of Science 
citation analysis covered any kind of institution and firm, at the global level.  
 
Figure 3. Overall (any industrial sector) technology citation and Health Sector technology 
citation (from January 2015 to April 2019) 
 
Source: Web of Science 
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Figure 4. Technology citations specifically related to the Health Sector (from January 
2015 to April 2019) 
 
 
 
Source: Web of Science 
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Critical actions. After the end of the Delphi, the workshops that were held in late April led to 
the identification of a set of actions for fostering the development and transfer of the relevant 
technologies identified in the Delphi process (especially Artificial Intelligence and Big Data 
Analytics) to the London based digital health SMEs. First of all, data access to NHS records is 
considered to be an essential enabler of new Artificial Intelligence based products and services, 
by helping SMEs to understand patients’ needs and problems and the role of new digital 
technologies in addressing these problems. Digital Healthcare start-ups often experience 
difficulties in accessing data due to their limited resources and networking. The way 
information is retrieved and collected from patients should include (and actually emphasize) 
intuition, from both patients and GPs, and their tacit knowledge. This will bring about a big 
opportunity to develop health records that combine health data, and social care.  
 
The second critical action regards collaboration with hospitals and medical centres. SMEs 
should team up with hospitals and clinical research team to enhance knowledge sharing, data 
access, funding, and build a vision for the future of digital healthcare. Such collaboration 
should involve as well universities, research centres, and stakeholders who can provide early 
feedback, accelerate knowledge transfer and information exchange.  
 
Third, education is necessary since early stages (e.g., primary school) foster the development 
of a favourable environment, enhancing mutual understanding and nurturing a wide range of 
capabilities in both service providers and final users, such as problem-solving, idea generation, 
analytical skills, networking and relational skills. These capabilities in turn would be beneficial 
to enhance the adoption of digital technologies and services.  
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Forth, it is necessary to define lead projects and products. SMEs need to focus on a selection 
of priorities in terms of products and services. Traditional NHS procurement practices often 
favour large corporations, by promoting large-scale projects (and procedures) that are too large 
for SMEs to bid for. By focusing on a few projects and products, SMEs can develop state-of 
the art skills that might ultimately enable them to partner with leading, large corporations. 
Contextually, standard public procurement procedures so be revised so that SMEs can have an 
easier understanding and access.  
 
Fifth, concerning funding, innovative approaches to fundraising were discussed during the 
workshop. Such approaches include crowdfunding, private venture capital and private equity. 
A relevant new trend in fund raising is Initial Coin Offering (ICO), which recently proved 
successful in enabling healthcare start-ups to raise money in a considerably short period of time 
(e.g. MedicalChain, Docademic). ICO involves the initial offering of a digital 
cryptographically secure piece of data (a digital token) created on a blockchain as part of a 
decentralised software protocol. An ICO is a popular way to raise money for a new project/start 
up by distributing a percentage of the initial currency supply to early supporters of the relevant 
project. Unlike conventional crowdfunding, however, tokens are usually tradable via online 
exchanges. This liquidity helps attract investors, and means that the overall ICO process has 
similarities with both conventional crowdfunding and an Initial Public Offering.  
 
5. Discussion and conclusions 
 
Our technology foresight project with UK digital health SMEs allowed us to gain some clear 
lessons on the potential benefits of such approach. First of all, the managers of UK SMEs are 
knowledgeable of new technologies and ready to take part in this kind of project because of the 
perceived benefits of the technology foresight approach to technology adoption.  
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Second, intermediaries and cluster stakeholders (e.g. the Digital health London Accelerator) 
can have a relevant role in supporting the recruitment of SMEs participating in foresight 
projects. Such intermediaries can enhance the trust in the researchers performing foresight 
projects and attract the interest of SME managers. 
 
Third, foresight can have a concrete impact on the investment decisions of SMEs. One of the 
managers participating in the project has already communicated his intention to start an 
artificial intelligence project (artificial intelligence is one of the critical technologies identified 
in the Delphi) and potentially involve one of the technology experts met during the workshops. 
Another manager pointed out that it would be very interesting to replicate our technology 
foresight project in other digital health clusters in the UK, e.g., Manchester or Nottingham, and 
compare the results – especially in relation to the feasibility of the relevant technologies 
identified in the Delphi. 
 
Limitations and future research 
The recruitment of digital health SMEs was potentially challenging but the development of 
links with Digital Health UK proved very beneficial for all parties. However, if there had been 
more time and resources for a UK wide technology foresight project, we could have been more 
selective in relation to the companies participating in the project, especially in relation to such 
dimensions as the stage of their life cycle, size, and capability to grow. Additionally, a longer 
project would enable more time to evaluate the concrete outcomes of the new technologies 
adopted in participating firms. Furthermore, we could increase the number of criteria (both 
attractiveness and feasibility) used to assess the future evolution and impact of the emerging 
digital health technologies, in relation to their specific likely applications (innovative products 
and services). Contextually, we could explore the use of public procurement for stimulating 
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the design and provision of innovative products/services (based on emerging technologies) 
from digital health SMEs. 
 
Our foresight project provided some clear indications and guidelines on how it can be scaled 
up. First of all, in order to improve the reliability and comprehensiveness of the results and 
outcomes, it would be helpful to: a) increase the number of SME managers and technology 
experts involved in the process; b) expand the time horizon of the project so that both the SME 
managers and experts can have more time for collecting and elaborating data. Second, our pilot 
project involved 15 SMEs from the Digital Health London Accelerator (DHLA). With the 
managers of DHLA we have already considered the opportunity to scale up the project and 
involve all the 85 companies associated with DHLA. In order to scale up the project and 
enhance its results and outcomes, it would be helpful to run the foresight process and apply our 
innovative methodology in two or three different clusters of digital health SMEs, e.g., the 
London cluster and the Nottingham cluster. This would allow to compare the results and to 
look for similarities and synergies between these different territories. Third, it would be helpful 
to increase the number of criteria (both attractiveness and feasibility) used to assess the future 
evolution and impact of the emerging digital health technologies, in relation in particular to 
their likely applications (innovative products and services). In particular, we aim to explore the 
use of public procurement (i.e., public measures which attempt to pull through innovations and 
the diffusion of innovations) for stimulating the design and provision of innovative 
products/services (based on emerging technologies) from digital health SMEs. Finally, it would 
be useful to apply our innovative foresight methodology to other sectors related to Digital 
Health, e.g., the digital game industry or the autonomous (self-driving) car sector. In this way, 
we can improve/expand the methodology itself and test/adapt it to different contexts, by 
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pointing out potential technological synergies and opportunities for collaboration among the 
SMEs of different (but related) sectors.   
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